Robert Azelby - 17 Jun 2024 Form 4 Insider Report for ADC Therapeutics SA (ADCT)

Role
Director
Signature
Lisa Kallebo, as Attorney-in-Fact for Robert Azelby
Issuer symbol
ADCT
Transactions as of
17 Jun 2024
Transactions value $
-$20,216
Form type
4
Filing time
18 Jun 2024, 21:45:33
Previous filing
14 Jun 2024
Next filing
07 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADCT Common Shares Sale -$20.2K -7K -11.66% $2.89 53K 17 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Common Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units.